Nestlé

Photo

Lonza and Moderna Extend Covid Vaccine Collaboration

Swiss CDMO Lonza and US vaccine maker Moderna have extended and deepened their collaboration on the US biotech’s mRNA- based Covid-19 shot. The new agreement, which calls for the installation of three new production lines and a doubling of existing drug substance production at Lonza’s Visp, Switzerland, site, builds on a 10-year pact signed last year.

Photo

Nestlé Boosts Allergy Offering with Aimmune

Nestlé Health Science has agreed to buy Aimmune Therapeutics, a US biopharma and developer of food allergy treatments. The Swiss multinational food and beverage conglomerate already owns about 25.6% of the company through investments worth $473 million made between November 2016 and January 2020.

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.